---

 

PRELIMINARY  PROGRAM

 

Day 1 — Afternoon (14:00–19:00) 

14:00– 14:15 
Opening & Welcome — Chair and Co-Chairs 

14:15 – 15:00 
Keynote Lecture (Surtees Lecture) — Manju Kurian 
Chaired by Alexis Arzimanoglou
 

Session 1: Phenotypes of Pediatric Paroxysmal Movement Disorders   
Chair: Jaume Campistol 

• 15:00 – 15:30 — E. Fernandez-Alvarez 
  Cataplexy: Phenomenology and Associated Conditions 

• 15:30 – 16:00 — R. Pons 
  Paroxysmal Movement Disorders in Metabolic Diseases 

• 16:00 – 16:30 — D. Ebrahimi-Fakhari 
  The Clinical and Molecular Spectrum of Epilepsy-Dyskinesia Syndromes 

 

16:30 – 17:00 — Coffee Break 

 

Session 2: Genomics and New Tools in Pediatric Dystonia
Chair: Angeles Garcia-Cazorla 

• 17:00 – 17:30 — M. Zech 
  A Genomics Approach to Dystonia: Results from a 10-Year Prospective Multinational Study 

• 17:30 – 18:00 —  A. Saparov 
  Transcriptomics Analysis Achieves New Solved Cases in Rare Undiagnosed Dystonia 

• 18:00 – 18:30 — L. Cif 
  CODY-SAMP: Combined Dystonia Scale for Assessment of Motor Phenotype 

• 18:30 – 19:00 — Discussion 

 

Day 2 — Full Day (09:00–18:00) 

 

Session 3: Rare Syndromes and Cerebral Palsy 
Chair: Birgit Assmann 

• 09:00 – 09:30 —  S. Galosi 
  The Etiological and Clinical Spectrum of Myoclonus-Ataxia Syndromes 

• 09:30 – 10:00 — D. Ortigoza 
  NKX2-1-related Disorders: Clinical Update and Registry-based Insights 

• 10:00 – 10:30 — M. Fahey 
  Genetics of Cerebral Palsy 
   

10:30 – 11:00 — Coffee Break 

 

Session 4: Neurophysiological Mechanisms and Emerging Therapies in Dystonia 
Chair: Anne Koy

• 11:00 – 11:30 — J. Mink 
  Motor Pattern Generators in the CNS – Relevance to Dystonia 

• 11:30 – 12:00 — A. Kaymak 
  Genetic Influences on Neurophysiology of Movement Disorders 

• 12:00 – 12:30 — V. Levi & G. Zorzi 
  Multimodal Network Analysis in Genetic Pediatric Dystonia with DBS 

• 12:30 – 12:45— Discussion 
   

12:45 – 13:45 — Lunch Break 

 

Session 5: Advances in Metal Accumulation Diseases 
Chair: Monica Troncoso 

• 13:45 – 14:15 — S. Hayflick 
  Emerging Therapeutics for PKAN 

• 14:15 – 14:45 — K. Yang
  Manganese-Metabolism Disorders in Children

• 14:45 – 15:15 — Discussion

 

15:15 – 15:45 — Coffee Break 

 

Session 6: Video Communications (Part I)
Chair: Daniela Muñoz 

• 15:45–16:00 — Video 1 : The Movement Disorder Spectrum of ATP1A3-Related Disorders: Cross-Sectional Analysis and Video Archive of 92 Patients - BERNARDI Katerina (United States)

  16:00–16:15 — Video 2 : Tremor and Myoclonus in Neurodevelopmental disorders: Neurophysiological Results From an Italian Multicentric Study on Inherited Synaptopathies - POLLINI Lucas (Italy)

  16:15–16:30 — Video 3 : Missense variants in the A isoform of FGF13 as a novel cause of paroxysmal dyskinesia - RAVELLI Claudia (France)

  16:30–16:45 — Video 4 : The First AADC partial deficiency identified at newborn screening in Western Sicily - SANTORO Laura (Italy)

  16:45–17:00 — Video 5 : KARS1-related DEE-MD with severe anemia: promising therapeutic response to oral lysine suplementation - YILMAZ Sanem (Türkiye)

  17:00–17:15 — Video 6 : Expanding the Genetic Landscape of cHSP: Clinical Evidence for SYNRG as a Novel Disease Gene - PERILLI Lorenzo (United Kingdom)

  17:15–17:45 — Discussion

 

Day 3 — Morning (09:00–13:00) 

Session 7: Video Communications (Part II)

Chair: Dario Ortigoza

• 09:00–09:15 — Video 7 : Utility of DaTscan in Children with Complex Juvenile Parkinsonism Phenotypes: A Single-Centre Cohort Study - SPAGARINO Antonio (United Kingdom)

  09:15–09:30 — Video 8 : Infantile Tremor Syndrome as a Treatable Movement Disorder: Clinical and Metabolic Insights from Six Cases - JAVED Iram (Pakistan)

  09:30–09:45 — Video 9 : Phenomenological Variability of Movement Disorders in ATP8A2-related Disorder Patients - HELALI Hadi (United Arabe Emirates)

  09:45–10:00 — Video 10 : Management of movement disorders in chronic neurological conditions and palliative care: a comprehensive analysis - RAMON-GOMEZ Jorge Luis (Colombia)

  10:00–10:15 — Video 11 : Pediatric Functional Motor Symptoms: Clinical Spectrum, Comorbidities, and Long-Term Outcomes - GUEDES VAZ Catarina (Portugal)

  10:15–10:45 — Discussion

10:45 – 11:15 — Coffee Break 
 

Session 8: Functional Movement Disorders 
Chair: Manju Kurian

• 11:15 – 11:45 — N. Nardocci 
  Functional Pediatric Movement Disorders: a neurodevelopmental and network-based perspective 

• 11:45 – 12:15 — E. Roze 
  The Clinical Spectrum of Functional Movement Disorders in Children: From Symptoms to Diagnosis 

• 12:15– 12:45 — Discussion 
   

Session 9: Emerging Directions: Epigenetics, AI, and Neuromodulation
Chair: Jonathan Mink

• 12:45 – 13:15 — R. Dale 
  Emerging Role of Epigenetics Affecting the Immune System and Brain in Neurodevelopmental Disorders 

• 13:15 – 13:45 — D. Lumsden 
  How Will AI Change the Management of Pediatric Movement Disorders? 

• 13:45 – 14:15 — J-P Lin
  Patient Selection and Decision-Making for DBS and ITB Neuromodulation in Childhood Dystonia: A 16-Year Cohort Study

14:15— Closing Remarks